130 related articles for article (PubMed ID: 3462303)
21. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
Michelsen B; Lernmark A
J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization by high-resolution isoelectric focusing of the products encoded by the class II region loci of the major histocompatibility complex in humans. I. DR and DQ gene variants.
Rodriguez de Cordoba S; Nunez-Roldan A; Winchester R; Marshall P; Carrier C; Mollen N; Walker M; Ginsberg-Fellner F; Rubinstein P
Hum Immunol; 1987 Sep; 20(1):71-93. PubMed ID: 3679903
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
24. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
[TBL] [Abstract][Full Text] [Related]
25. Application of synthetic oligonucleotides to detect DQ beta genes transmission within insulin-dependent diabetes families.
Toyoda H; Onohara-Toyoda M; Krull J; Vadheim CM; Bickal JC; Riley WJ; MacLaren NK; Itakura K; Rotter JI
Dis Markers; 1989; 7(4):215-28. PubMed ID: 2573447
[TBL] [Abstract][Full Text] [Related]
26. HLA-DQ structural polymorphism in HLA-DR2 associated HLA-D clusters.
Nakatsuji T; Moriya K; Ando A; Inoko H; Tsuji K
Hum Immunol; 1986 Jun; 16(2):157-62. PubMed ID: 2941397
[TBL] [Abstract][Full Text] [Related]
27. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
28. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
Nuñez G; Stastny P
Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
[TBL] [Abstract][Full Text] [Related]
29. HLA-DQ beta-chain restriction fragment length polymorphism as a risk marker in type 1 (insulin-dependent) diabetes mellitus: a Finnish family study.
Reijonen H; Ilonen J; Knip M; Michelsen B; Akerblom HK
Diabetologia; 1990 Jun; 33(6):357-62. PubMed ID: 1974216
[TBL] [Abstract][Full Text] [Related]
30. HLA-DR2, -DR5, and DRw6 associated Dw subtypes correlate with HLA-DR beta and -DQ beta restriction fragment length polymorphisms.
Font MP; Gebuhrer L; Betuel H; Freidel C; Dausset J; Cohen D
Proc Natl Acad Sci U S A; 1986 May; 83(10):3361-5. PubMed ID: 3010292
[TBL] [Abstract][Full Text] [Related]
31. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.
Nepom BS; Palmer J; Kim SJ; Hansen JA; Holbeck SL; Nepom GT
J Exp Med; 1986 Jul; 164(1):345-50. PubMed ID: 3014039
[TBL] [Abstract][Full Text] [Related]
32. Applicability of HLA-DQB oligonucleotide typing for the TA10 and 2B3 specificities in routine HLA typing.
Vijverberg K; Schreuder GM; Kenter MJ; Naipal AM; van Rood JJ; Giphart MJ
Tissue Antigens; 1990 Apr; 35(4):165-71. PubMed ID: 1695394
[TBL] [Abstract][Full Text] [Related]
33. Multiple epitopes on a single DQ molecule from the DQw3-carrying haplotypes.
Maeda H; Hirata R; Kambayashi H; Koning F; Schreuder GM
Tissue Antigens; 1986 Sep; 28(3):136-45. PubMed ID: 2431512
[TBL] [Abstract][Full Text] [Related]
34. HLA DQ beta restriction fragment length polymorphism and rheumatoid arthritis. Association between DQw7 and rheumatoid arthritis in DR4-positive subjects.
Rousseau J; du Toit ED; Meyers OL; Ress SR
S Afr Med J; 1991 Mar; 79(6):323-5. PubMed ID: 1673266
[TBL] [Abstract][Full Text] [Related]
35. Identification of two subtypes of HLA-DR2 by Southern blot analysis.
Singal DP; Butler L; Lamontagne L
Tissue Antigens; 1986 Jul; 28(1):29-40. PubMed ID: 3018959
[TBL] [Abstract][Full Text] [Related]
36. DNA restriction fragment length polymorphism of HLA-DR2: correlation with HLA-DR2-associated functions.
Jacobson S; Sorrentino R; Nepom GT; McFarlin DE; Strominger JL
J Neuroimmunol; 1986 Sep; 12(3):195-203. PubMed ID: 3016025
[TBL] [Abstract][Full Text] [Related]
37. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR4-associated haplotypes are genotypically diverse within HLA.
Holbeck SL; Kim SJ; Silver J; Hansen JA; Nepom GT
J Immunol; 1985 Jul; 135(1):637-41. PubMed ID: 2987355
[TBL] [Abstract][Full Text] [Related]
39. Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci.
Arnheim N; Strange C; Erlich H
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6970-4. PubMed ID: 2995996
[TBL] [Abstract][Full Text] [Related]
40. HLA-DQw3-related determinants: analysis of subunit and spatial relationships.
Radka SF; Nelson KA; Johnston JV
Hum Immunol; 1989 Aug; 25(4):225-36. PubMed ID: 2475476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
